Literature DB >> 6792316

Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates.

P H Wooley, H S Luthra, J M Stuart, C S David.   

Abstract

A model of arthritis was established by the injection of type II collagen into mice. Only mice bearing the H-2q haplotype were susceptible to the disease. Susceptibility was further mapped by the use of recombinant strains on the Iq locus. Type II collagen arthritis was observed in the (resistant X susceptible) F1 cross. Mice strains were designated high, intermediate, or low responders with respect to the anti-type II antibody levels measured by radioimmunoassay. Arthritis-susceptible strains were all classified as high antibody responders. The clinical and histological appearance of type II collagen arthritis in the mouse indicates that it may be a good animal model for the investigation of various immunogenetic traits in rheumatoid arthritis.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6792316      PMCID： PMC2186443          DOI： 10.1084/jem.154.3.688

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  16 in total

1.  H-2-linked genetic control of antibody response to soluble calf skin collagen in mice.

Authors:  E Hahn; H Nowack; D GOTZE; R Timpl
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

2.  Passive transfer by cells of type II collagen-induced arthritis in rats.

Authors:  D E Trentham; R A Dynesius; J R David
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

3.  Solid-phase radioimmunoassay for the detection of antibodies to collagen.

Authors:  R B Clague; R A Brown; J B Weiss; P J Holt
Journal:  J Immunol Methods       Date:  1979-05-10       Impact factor: 2.303

Review 4.  Protein clinical manifestations of primary tumors of the heart.

Authors:  H O McDevitt; W F Bodmer
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

Review 5.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

6.  Localization of antigenic activity and immunogenic capacity in different conformational domains of procollagen peptide.

Authors:  H Rohde; H Nowack; R Timpl
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

7.  Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis.

Authors:  N A Andriopoulos; J Mestecky; E J Miller; E L Bradley
Journal:  Arthritis Rheum       Date:  1976 May-Jun

8.  Cellular sensitivity to collagen in rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius; R E Rocklin; J R David
Journal:  N Engl J Med       Date:  1978-08-17       Impact factor: 91.245

9.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice.

Authors:  H O McDevitt; M Sela
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307
View more
  195 in total

1.  Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model.

Authors:  Teresa K Tarrant; Peng Liu; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Roman G Timoshchenko; Marcus W McGinnis; David J Fitzhugh; Dhavalkumar D Patel; Alan M Fong
Journal:  Arthritis Rheum       Date:  2012-05

2.  Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Dorota Klaczkowska; Malin Hultqvist; Kristin Hagenow; Rikard Holmdahl; Kutty Selva Nandakumar
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

Review 3.  Association of MHC and rheumatoid arthritis. Regulatory role of HLA class II molecules in animal models of RA: studies on transgenic/knockout mice.

Authors:  V Taneja; C S David
Journal:  Arthritis Res       Date:  2000-04-12

4.  Suppression of murine collagen-induced arthritis by nasal administration of collagen.

Authors:  L K Myers; J M Seyer; J M Stuart; A H Kang
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

5.  Restricted heterogeneity in T-cell antigen receptor V beta gene usage in the lymph nodes and arthritic joints of mice.

Authors:  T M Haqqi; G D Anderson; S Banerjee; C S David
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

6.  The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.

Authors:  Mae-Xhum Wong; John D Hayball; P Mark Hogarth; Denise E Jackson
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

7.  A study on type II collagen-induced arthritis in allogeneic bone marrow chimaeras.

Authors:  M Fujita; M Mishima; K Iwabuchi; C Katsume; T Gotohda; K Ogasawara; Y Mizuno; R A Good; K Onoé
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

8.  Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.

Authors:  Kristine A Kuhn; Liudmila Kulik; Beren Tomooka; Kristin J Braschler; William P Arend; William H Robinson; V Michael Holers
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

9.  IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints.

Authors:  C-Q Chu; Z Song; L Mayton; B Wu; P H Wooley
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

10.  The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.